The Clinical Outcomes of Covid-19 in Hiv-Positive Patients: A Systematic Review of Current Evidence Publisher Pubmed



Seyedalinaghi S¹ ; Karimi A² ; Mohssenipour M¹ ; Barzegary A³ ; Mirghaderi SP² ; Fakhfouri A³ ; Saeidi S⁴ ; Razi A⁵ ; Mojdeganlou H⁶ ; Tantuoyir MM^{2, 7} ; Afsahi AM⁸ ; Mehraeen E^{9, 10} ; Dadras O¹¹
Source: Immunity# Inflammation and Disease Published:2021

Abstract

Introduction: Patients with chronic underlying diseases are more susceptible to coronavirus disease 2019 (COVID-19) complications. Recent studies showed people living with HIV (PLWH) are not at greater risk than the general population. Few studies have reviewed the impacts of COVID-19 on PLWH. The purpose of this systematic review was to investigate the impact of COVID-19 on patients infected with HIV. Methods: We executed a systematic search using four databases of PubMed, Scopus, Science Direct, and Web of Science and screened the records in two steps based on their title/abstract and full text. This study follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist to elevate the validity and reliability of its results. Results: We reviewed 36 studies. The patients' age was above 20 years in all studies. In almost all studies, the inflammatory parameters were reported high. In most of the studies, all HIV patients completely recovered from the COVID 19 infection. Although CD4 count was not recorded in all studies, the minimum level was reported as 12 cells/µl. Conclusion: Based on the current review, we concluded that HIV patients at advanced stages (3 or 4) of the disease, whose CD4 counts are low, may show less severe COVID-19 infection symptoms. Similarly, Interference can reduce the severity of immune reactions and subsequent cytokine storms and consequently mitigate the symptoms. Therefore, in most of the studies, the majority of HIV patients showed no severe symptoms and completely recovered from COVID 19 infection. © 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.